EUVIMEDEUVIMED entdecken
Open Access

Nrf3 promotes the proliferation and migration of triple‑negative breast cancer by activating PI3K/AKT/mTOR and epithelial‑mesenchymal transition

Wan-Meng Chen, Qing-Yong Hu, Wei Hou, Meng-Wei Chen, Ya-Hui Chen, Jian-Cai Tang

Oncology Letters · 28.08.2023 · 26 (4)

DOI: 10.3892/ol.2023.14030 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncology Letters, online erschienen am 28.08.2023. Verfasst von Wan-Meng Chen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Institute of Basic Medicine and Forensics Medicine, North Sichuan Medical College, Nanchong, Sichuan 637000, P.R. China. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nuclear factor erythroid 2-related factor 3 (Nrf3) is increasingly implicated in multiple types of cancer; however, its function in triple-negative breast cancer (TNBC) remains unclear. This study aimed to examine the role of Nrf3 in TNBC. Compared with adjacent normal tissues, TNBC tissues expressed higher levels of Nrf3, and its expression was negatively correlated with survival time. Additionally, Nrf3 knockdown reduced the proliferation and migration of TNBC cells, whereas overexpression of Nrf3 had the opposite effects in vitro and in vivo. Moreover, functional enrichment of TNBC cells overexpressing Nrf3 allowed for the identification of numerous genes and pathways that were altered following Nrf3 overexpression. Further study showed that overexpression of Nrf3 activated the PI3K/AKT/mTOR signaling pathway and regulated the expression of proteins associated with epithelial-mesenchymal transition. Nrf3 was found to directly bind to p110α promoter regions, as evidenced by luciferase reporter and chromatin immunoprecipitation assays. Furthermore, PI3K inhibitors partially decreased the proliferation and migration of the Nrf3 overexpressing TNBC cells. In conclusion, Nrf3 enhances cellular proliferation and migration by activating PI3K/AKT/mTOR signaling pathways, highlighting a novel therapeutic target for TNBC.

Schlagwörter

Stichwörter der Autor:innen

PI3K/Akt/mTORepithelial-mesenchymal transitionnuclear factor erythroid 2-related factor 3proliferation and migrationtriple-negative breast cancer

Autor:innen und Institutionen

  • Department of Biochemistry, Institute of Basic Medicine and Forensics Medicine, North Sichuan Medical College, Nanchong, Sichuan 637000, P.R. China.

Zitieren

APA

Chen, W. M., Hu, Q. Y., Hou, W., Chen, M. W., Chen, Y. H., & Tang, J. C. (2023). Nrf3 promotes the proliferation and migration of triple‑negative breast cancer by activating PI3K/AKT/mTOR and epithelial‑mesenchymal transition. Oncology Letters, 26(4). https://doi.org/10.3892/ol.2023.14030

Vancouver

Chen WM, Hu QY, Hou W, Chen MW, Chen YH, Tang JC. Nrf3 promotes the proliferation and migration of triple‑negative breast cancer by activating PI3K/AKT/mTOR and epithelial‑mesenchymal transition. Oncology Letters. 2023;26(4). doi:10.3892/ol.2023.14030

BibTeX
@article{Chen2023,
  author = {Chen, Wan-Meng and Hu, Qing-Yong and Hou, Wei and Chen, Meng-Wei and Chen, Ya-Hui and Tang, Jian-Cai},
  title = {Nrf3 promotes the proliferation and migration of triple‑negative breast cancer by activating PI3K/AKT/mTOR and epithelial‑mesenchymal transition},
  journal = {Oncology Letters},
  year = {2023},
  volume = {26},
  number = {4},
  doi = {10.3892/ol.2023.14030}
}
Kostenlos starten →